GHRP-2 vs GHRP-6: What Is the Difference? (Research Overview)

Both GHRP-2 and GHRP-6 are synthetic growth-hormone-releasing peptides (GHRPs) that act as agonists at the ghrelin receptor (GHS-R1a). The key difference studied in the lab is that GHRP-6 is associated with stronger appetite-stimulating (ghrelin-like) signaling in animal models, while GHRP-2 is often characterized as a more potent growth-hormone (GH) secretagogue relative to its other effects. This article is an educational research overview for context only.

Research-use-only (RUO) note: GHRP-2 and GHRP-6 are research chemicals intended for in-vitro and laboratory study. They are not drugs, supplements, or food. Nothing here describes human use, and all findings below refer to preclinical (in-vitro and animal) research. Bolt Peptide does not currently stock either compound.

Quick comparison

Attribute	GHRP-2	GHRP-6
Class	Synthetic GHRP / GH secretagogue	Synthetic GHRP / GH secretagogue
Structure	Heptapeptide (7 amino acids)	Hexapeptide (6 amino acids)
Receptor (research)	Agonist at ghrelin receptor (GHS-R1a)	Agonist at ghrelin receptor (GHS-R1a)
Relative profile in studies	Characterized as a potent GH secretagogue in pituitary-cell models	Founding GHRP; strongly linked to ghrelin-like appetite signaling in animal models

What is GHRP-2?

GHRP-2 (also written as pralmorelin in research literature) is a synthetic heptapeptide belonging to the growth-hormone-releasing peptide family. In preclinical work it acts as an agonist at the growth hormone secretagogue receptor type 1a (GHS-R1a) — the same receptor that the endogenous hormone ghrelin binds. In isolated rat pituitary-cell studies, GHRP-2 stimulated GH release through the same receptor and mechanism as GHRP-6 and acted synergistically with growth-hormone-releasing factor (GRF) in that model.

What is GHRP-6?

GHRP-6 is a synthetic hexapeptide and the historical founding member of the GHRP class — the compound whose study helped lead researchers to the ghrelin receptor and, ultimately, to ghrelin itself. Like GHRP-2, GHRP-6 acts as a GHS-R1a agonist in research models. It is frequently used in animal studies as a ghrelin-mimetic tool because its signaling overlaps closely with that of native ghrelin.

Key differences studied in the lab

• Structure: GHRP-2 is a heptapeptide (7 amino acids); GHRP-6 is a hexapeptide (6 amino acids).
• Shared mechanism: in rat primary pituitary cells, both peptides stimulated GH release via the same receptor and mechanism, and combining them at maximal concentrations produced no greater effect than either alone — consistent with a common pathway.
• Appetite-related signaling: in animal models, GHRP-6 has been characterized as a strong ghrelin-like appetite signal; central administration stimulated food intake and activated hypothalamic appetite centers in rats, and GHRP-6 was equipotent to ghrelin for stimulating food intake in goldfish.

How they relate to other secretagogues

GHRP-2 and GHRP-6 are early-generation members of the GHRP class. Later research produced more selective compounds: Ipamorelin is a later, more selective GHRP frequently described as having a comparatively narrow secretagogue profile. Outside the peptide family, MK-677 (ibutamoren) is a non-peptide, orally studied ghrelin-receptor agonist. All four are studied as growth hormone secretagogues but differ in structure, selectivity, and route used in research settings.

Research status and safety

GHRP-2 and GHRP-6 are research chemicals. They are not approved drugs, dietary supplements, or food, and they are not for human or veterinary use. Any data summarized here come from in-vitro and animal studies and are presented strictly for scientific and educational context.

Handling

Lyophilized research peptides are typically prepared for in-vitro work by reconstitution before use. For general technique, see our reconstitution guide, and browse compounds currently stocked in the peptide catalog.

FAQ

Are GHRP-2 and GHRP-6 the same thing? No. They are distinct synthetic peptides — GHRP-2 is a 7-amino-acid heptapeptide and GHRP-6 is a 6-amino-acid hexapeptide — but in pituitary-cell research they act through the same ghrelin (GHS-R1a) receptor and mechanism.

Which one is “stronger”? That depends on the endpoint measured in a given study. GHRP-2 is often characterized as a potent GH secretagogue, while GHRP-6 is more strongly associated with ghrelin-like appetite signaling in animal models. These are research observations, not claims about effects in humans.

Can I use these compounds? No. Both are research-use-only and are not intended for human consumption, diagnosis, or treatment.

References

1. Cheng J, et al. A comparison of the GH-releasing activities of GHRP-2 and GHRP-6 in rat primary pituitary cells. Life Sci. 1997.
2. Lawrence CB, et al. Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centers. Endocrinology. 2002.
3. Yahashi S, et al. GHRP-6 mimics ghrelin-induced stimulation of food intake in goldfish. Peptides. 2012.

For research use only. Not for human or veterinary use; not a drug, supplement, or food. Statements have not been evaluated by the FDA.